Screening assays that allow for the identification of agents that modulate CTGF-mediated NF-κB activity. Such agents are useful, for example, for diagnosing CTGF-mediated NF-κB associated disorders in subjects, and treating the subjects with the agents identified as being ale to modulate CTGF-mediated NF-κB activity.
展开▼